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Abstract
Background: The helminth Schistosoma mansoni parasite resides in mesenteric veins where fecundated female worms lay
hundred of eggs daily. Some of the egg antigens are trapped in the liver and induce a vigorous granulomatous response.
High Mobility Group Box 1 (HMGB1), a nuclear factor, can also be secreted and act as a cytokine. Schistosome HMGB1
(SmHMGB1) is secreted by the eggs and stimulate the production of key cytokines involved in the pathology of
schistosomiasis. Thus, understanding the mechanism of SmHMGB1 release becomes mandatory. Here, we addressed the
question of how the nuclear SmHMGB1 can reach the extracellular space.
Principal Findings: We showed in vitro and in vivo that CK2 phosphorylation was involved in the nucleocytoplasmic
shuttling of SmHMGB1. By site-directed mutagenesis we mapped the two serine residues of SmHMGB1 that were
phosphorylated by CK2. By DNA bending and supercoiling assays we showed that CK2 phosphorylation of SmHMGB1 had
no effect in the DNA binding activities of the protein. We showed by electron microscopy, as well as by cell transfection and
fluorescence microscopy that SmHMGB1 was present in the nucleus and cytoplasm of adult schistosomes and mammalian
cells. In addition, we showed that treatments of the cells with either a phosphatase or a CK2 inhibitor were able to enhance
or block, respectively, the cellular traffic of SmHMGB1. Importantly, we showed by confocal microscopy and biochemically
that SmHMGB1 is significantly secreted by S. mansoni eggs of infected animals and that SmHMGB1 that were localized in
the periovular schistosomotic granuloma were phosphorylated.
Conclusions: We showed that secretion of SmHMGB1 is regulated by phosphorylation. Moreover, our results suggest that
egg-secreted SmHMGB1 may represent a new egg antigen. Therefore, the identification of drugs that specifically target
phosphorylation of SmHMGB1 might block its secretion and interfere with the pathogenesis of schistosomiasis.
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Introduction
Schistosomes are parasitic blood flukes infecting approximately
200 million people globally [1]. Schistosoma mansoni parasites reside
in mesenteric veins, where they lay hundreds of eggs per day, 4–5
weeks post-infection. After initial infection, larval and adult
parasites produce minimal inflammatory pathology in the host.
However, by the time the eggs are laid, some of them are trapped
in the microvasculature of the liver causing the granuloma, due to
a periovular inflammatory reaction. Granulomas are initially
macrophage reactions of the foreign body type, essentially
mobilizing the circulating monocytes. Following maturation of
the embryo (miracidium) and secretion of potent soluble egg
antigens, the T-lymphocyte circuits elicit an inflammatory reaction
promoting cellular recruitment and activation, which are depen-
dent upon the local production of a vast array of cytokines [2–4].
The pre-postural phase of schistosomal infection is characterized
by a Th1 dominant reaction. After the beginning of oviposition,
the egg-derived antigens elicit a strong Th2 reaction with high
levels of IL-4 and IL-5 [2]. The intensity of the granulomatous
reaction peaks in mice from the 7
th week onwards, but
subsequently the inflammation reaction is down-modulated
despite the continuous production of adult worm and egg-derived
antigens. Much of the morbidity of schistosomiasis is attributed to
the egg-induced granulomatous responses, particularly to the
fibrosis associated with it, which is thought to be associated with
periportal hypertension. Although Praziquantel is highly effective
in curing S. mansoni infection, liver granulomas persist for life, as
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morbidity associated with liver egg granulomas would represent a
major improvement in the pathology of schistosomiasis.
High Mobility Group Box 1 (HMGB1) is a highly conserved
component of eukaryotic nuclei [5–6]. HMGB1 is ubiquitous and
only slightly less abundant than core histones. It has a tripartite
structure, composed of two homologous DNA-binding domains,
the A and B HMG-boxes, and a C-terminal acidic domain [5].
HMGB1 is located in the nucleus, where it acts as an architectural
protein that can promote DNA bending, supercoiling and
unwinding. These DNA transactions performed by HMGB1
promote the assembly of site-specific DNA-binding factors, and
are involved in transcription [7]. The phenotype of Hmgb1
knockout mice confirmed the functional importance of HMGB1
as a regulator of transcription: they die shortly after birth showing
a defect in transcriptional control exerted by the glucocorticoid
receptor [8].
In addition to transcriptional regulation, HMGB1 has extra-
cellular roles. In 1999, during a course of experiments designed to
identify late-acting mediators of endotoxaemia and sepsis, it was
discovered [9] that activated macrophages secrete HMGB1 as a
delayed mediator of inflammation. HMGB1 is regarded as a
prototypic alarmin, a kind of endogenous danger-associated
molecular patter (DAMP), as it is released by necrotic (but not
apoptotic) cells or secreted by immune cells in response to tissue
damage [10]. Activated macrophages secrete HMGB1 as a
delayed mediator of inflammation, well after peak of TNF-a and
IL-1 [9]. HMGB1 promotes monocytes recruitment and release of
pro-inflammatory cytokines such as TNF-a, IL-1, IL-6 and IL-8
[9–12], signaling through RAGE (receptor for advanced glycation
end-products) [13], toll-like receptor 2 (TLR2) and TLR4 [14–15].
The delayed HMGB1 release can have lethal consequences in
sepsis, as administration of HMGB1-specific antibodies confers
significant protection against mortality in endotoxaemia [10].
Thus, secreted HMGB1 also functions as an inflammatory
cytokine, and its secretion is pivotal in sepsis. Nevertheless, the
exact mechanism(s) that control(s) its secretion is still poorly
understood.
Recent studies have shown that the post-translational modifi-
cation status of mammalian HMGB1 (mHMGB1) is related to its
translocation within cells and secretion by inflammatory cells, in
which it shuttles between the nucleus and cytoplasm through a
process that involves the HMGB1 hyperacetylation [6]. Cytosolic
mHMGB1 accumulates and is secreted through a vesicle-mediated
secretory pathway [6]. More recently however, it has been
reported that phosphorylation [16–19], methylation [20] and poly
(ADP) ribosylation [21] also play a role in the cellular traffic of
mHMGB1.
Along with histone H1, HMGB1 protein appear to be among
the most highly phosphorylated protein species in the nucleus [22].
Phosphorylation of HMGB1 proteins from plants and insects has
been reported to modulate their stability and DNA binding
activities [23–25]. For example, phosphorylation of maize
HMGB1 by CK2 increases the negative net charge of the acidic
tail, which strengthens electrostatic interactions with the HMG-
box basic domains. Accordingly, phosphorylation reduced the
affinity of maize HMGB1 for linear DNA [24]. Similarly,
phosphorylation of insect HMGB1 proteins by PKC resulted in
a tenfold reduction of their DNA binding strength [25]. For the
mammalian HMGB1 protein, the role of phosphorylation on its
DNA binding activities has not yet been well documented. On the
other hand, it has been recently reported that PKC and CaMK
phosphorylation plays an important role in the nucleocytoplasmic
transport of mHMGB1 [16–19]. It was shown that the shuttling of
mHMGB1 between the nucleus and cytoplasm is tightly controlled
by the phosphorylation of the two nuclear localization signals
(NLS) of mHMGB1 [20].
We have previously cloned the S. mansoni HMGB1 cDNA and
have fully characterized its DNA-related activities [26].
SmHMGB1 showed a high degree of conservation among the
HMG box domains when compared to its mammalian counter-
part [26]. However, SmHMGB1 differed significantly in its C-
terminal acidic tail, consisting of only five acidic residues
(mHMGB1 contains 30 continuous acidic residues in its tail).
Results from Gnanasekar et al [27] investigating the pro-
inflammatory activities of SmHMGB1, showed in vitro that
significant levels of SmHMGB1 were present in excretory
secretions of eggs. They also showed that SmHMGB1 was a
potent inducer of pro-inflammatory cytokines such as TNF-a, IL-
1Ra, IL-2Ra, IL-6, IL-13, IL-13a1, IL-15 and MIP-1a from
peritoneal macrophages [27]. The TNF-a-inducing effect was a
function of the B box domain of SmHMGB1 (similar to the
mammalian HMGB1) and this effect could be blocked by
neutralizing antibodies against SmHMGB1 [27]. These findings
pose SmHMGB1 as a major inflammatory factor among egg
excretory secretions and an attractive candidate to be targeted by
chemotherapy in schistosomiasis.
Hyperacetylation of SmHMGB1 is important for its exit to the
extracellular milieu, as we have recently shown [28]. Here, we
showed that besides acetylation, SmHMGB1 is phosphorylated by
CK2, PKA and PKC, and provided evidence that phosphoryla-
tion by CK2 plays an important role in the translocation of
SmHMGB1 from the nucleus to the cytoplasm. However, we
demonstrated that phosphorylation of recombinant or endogenous
SmHMGB1 did not affect its DNA binding activity. Finally, we
showed that SmHMGB1 proteins that were located in the
cytoplasm of adult worms, in egg secretions or in the periovular
granuloma, were phosphorylated, indicating that phosphorylation
actively participates in SmHMGB1 secretion.
In the present work we describe the molecular characterization
of the mechanism of SmHMGB1 transfer from the nucleus to the
cytoplasm, culminating with its extracellular release. Furthermore,
we hypothesize that SmHMGB1 might act as an important
immune modulator for the development of the hepatic schistoso-
motic granuloma.
Materials and Methods
Ethics statement
All animals were handled in strict accordance with good animal
practice as defined by Animals Use Ethics Committee of UFRJ
(Universidade Federal do Rio de Janeiro), with approval ID #
IBqM 038. The study was conducted adhering to the institution’s
guidelines for animal husbandry.
Plasmids
Complementary DNAs encoding recombinant SmHMGB1-FL,
SmHMGB1-DC, SmHMGB1-box domain A and SmHMGB1-
box domain B were previously described [26]. Complementary
DNAs encoding recombinant single or double amino acid mutants
(S172A, S174A and S172A/S174A) were amplified by RT-PCR
using sense primer F1 (59-GGATCCATGGCTGAAGACAAGGG-
TAAG- 39)( BamHI restriction site is in italic and initiation codon is
underlined) and anti-sense primers M1 (59AAGCTTCTAATCGT-
CAGACTCTGCATCTTC39) for the SmHMGB1 S172A, M2
(59AAGCTTCTAATCGTCTGCCTCTGAATCTTC39) for the
SmHMGB1 S174A and M3 (59AAGCTTCTAATCGTCTGC-
CTCTGCATCTTC39) for the SmHMGB1 S172A/S174A (Hin-
Phosphorylation Mediates Schistosome HMGB1 Release
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underlined). RT-PCR was performed on S. mansoni adult worm
cDNAs, sub-cloned into pCR2.1 TOPO plasmid (Invitrogen), and
sequenced on both strands (Macrogen Inc., Korea). In order to
generate recombinant his-tagged proteins, plasmids were digested
with the appropriate enzymes (Promega) and cloned into the pQE-
80L expression vector (Qiagen), according to the manufacturer’s
instructions. For EGFP analysis, cDNAs encoding SmHMGB1
full-length (SmHMGB1-FL, aa residues 1–176) or SmHMGB1
mutated at both serines located in its C-terminus (S172A/S174A)
were cloned downstream of EGFP in pEGFP-C3 vector (BD
Clontech), and these constructs named EGFP-SmHMGB1 and
EGFP-SmHMGB1-S172A/S174A, respectively. We generated
these constructs by PCR amplifications using S. mansoni adult
worm cDNAs with the sense primer F2 (59-AAGCTTATGGCT-
GAAGACAAGGGTAAG-39)( HindIII restriction site is in italic
and initiation codon is underlined) and anti-sense primers F3
(59GGATCCCTAATCGTCAGACTCTGAATC39) and M4
(59GGATCCCTAATCGTCTGCCTCTGCATC39) for the full-
length SmHMGB1.
Expression of recombinant proteins and polyclonal
antibody production
Full-length SmHMGB1 (aa residues 1–176), the protein lacking
its acidic tail, SmHMGB1-DC (aa residues 1–169), domain A only
(aa residues 1–83), domain B only (aa residues 84–169) and
SmHMGB1 mutants (S172A, S174A and S172A/S174A) were
expressed with (His)6-tag at their N-termini as previously described
[26]. Protein concentration was determined by the Bio-Rad
Protein Assay (Bio-Rad). Purity of HMGB1 proteins was checked
by 12 or 15% SDS-PAGE, followed by Coomassie Blue R-250
staining. Polyclonal rabbit serum was produced against prepara-
tions of recombinant SmHMGB1-box domain B. Rabbits were
inoculated with 50 mg of protein mixed with complete Freund’s
adjuvant (SIGMA) and boosted four times with 50 mg of protein
mixed with incomplete Freund’s adjuvant (SIGMA). Pre-immune
serum was collected before the first immunization.
Phosphorylation assays
Recombinant SmHMGB1 proteins (1 mg) were phosphorylated
by commercial rat protein kinase CK2 (Promega), human protein
kinase A (PKA) (Millipore), rat protein kinase C (PKC) (Promega)
or by using S. mansoni total protein extract as a source of kinases.
Reactions were carried out in CK2 buffer (25 mM Tris-HCl,
pH 7.4, 200 mM NaCl, 10 mM MgCl2, and 0.1 mM ATP), at
37uC at different times, PKA buffer (100 mM HEPES, pH 7.0,
KCl 200 mM , 20 mM MgCl2, 0,1 mM ATP) and PKC buffer
(30 mM Tris-HCl, pH 7.6, 2 mM dithiothreitol, 6 mM
Mg(CH3COO)2, 0.4 mM CaCl2, 0,6 mg 1,2-Diacyl-sn-glycero-3-
phospho-L-serine, 0,12 mM ATP) for one hour at 30uC.
Reactions were carried out in the presence of 1 mCi [c
32P]ATP
(PerkimElmer). The reaction was stopped by adding SDS-PAGE
sample buffer (50 mM Tris-HCl pH 6.8, 2% SDS, 0.1%
bromophenol blue, 10% glycerol and 100 mM dithiothreitol).
For the unphosphorylated control reactions, proteins were
incubated in phosphorylation reactions lacking the protein kinase,
ATP or buffer. The phosphorylation status of the proteins was
examined by autoradiography and protein input controls were
examined by Coomassie Blue R-250 staining.
DNA supercoiling assay
DNA supercoiling assays were carried out as previously
described [24]. Briefly, CsCl-purified supercoiled plasmid
pTZ19R was relaxed at a DNA concentration ,170 mg/ml in
Topoisomerase I (Topo I) relaxation buffer (50 mM NaCl, 50 mM
Tris–HCl, pH 7.5, 1 mM EDTA, 20% glycerol and 1 mM
dithiothreitol) in the presence of topo I (2 units/mg DNA;
Promega) at 37uC for 90 min. The relaxed DNA (0.5 mg DNA)
was then diluted to final 40 mM NaCl, then the same amount of
the Topo I was added, followed by the addition of recombinant
SmHMGB1 proteins. The 20 ml reactions were allowed to
proceed at 37uC for 60 min after which they were terminated
by addition of SDS and NaCl to final 1% and 1 M, respectively.
DNA was deproteinized by chloroform/isoamyl alcohol (24:1)
extraction in the presence of 0.02% linear polyacrylamide (LPA,
SIGMA). Deproteinized DNA was then precipitated with 2.5
volume of ethanol, washed with 70% ethanol, air-dried and finally
dissolved in TE buffer. The occourance of DNA topoisomers was
analyzed by electrophoresis in 1% agarose gels in 16TBE buffer
at 3 V/cm for 17 h. The gels were stained with 0.5 mg/ml
ethidium bromide, distained in water and photographed through a
red filter in an UV-transilluminator (Mini-Bis Pro, Bio Imaging
Systems).
T4 DNA ligase-mediated circularization assay
The circularization assay (or bending assay) was carried out as
previously described [26]. Briefly, a
32P-labeled-66-bp or a
32P-
labeled-123-bp DNA fragments [29] (1 nM) with cohesive BamHI
ends were pre-incubated on ice for 20 min with appropriate
amounts of recombinant proteins (50 ng), total (10 mg), nuclear
(4 mg) or cytoplasmic (4 mg) adult worm extracts, in 16T4 DNA
ligase buffer (30 mM Tris–HCl, pH 7.8, 10 mM MgCl2,1 0m M
dithiothreitol, and 0.5 mM ATP; Promega) in a final volume of
20 ml. The DNA was then ligated with T4 DNA ligase (0.6 unit/
reaction; Promega) at 30uC for 30 min, and the ligation reactions
were terminated by incubation of samples at 65uC for 15 min.
Some of the ligation mixtures were digested after termination of
ligations with ,25 units of Exonuclease III (Promega) at 37uC for
30 min. Recombinant SmHMGB1 or protein extracts were pre-
incubated in the presence or absence of anti-SmHMGB1
antibody, pre-immune serum or heparin for 30 min at room
temperature before ligase reactions. Before electrophoresis, all
DNA samples were deproteinized as described in the DNA
supercoiling assay. The protein-free DNAs were loaded on pre-run
6% polyacrylamide gels in 0.56TBE buffer, and finally resolved
at 200 V for 2.5 h at 4uC. After electrophoresis, the gels were
vacuum-dried and visualized by autoradiography or Phosphor-
Imager STORM 860 (Molecular Dynamics) using Image Quant
5.2 software.
Cell culture and transfections
For cell work, a heterologous system was chosen since there is
no schistosome cell line available until today (recently reviewed by
Quack et al. [30]. HeLa cells (CCL-2, purchased from ATCC
TM)
were plated on glass coverslips in 24-well dish (80,000 cells/dish)
and cultured in RPMI 1640 medium supplemented with 10% fetal
bovine serum, in 5% CO2 humidified atmosphere. The cells were
transiently transfected with 1 mg of pEGFP-SmHMGB1, pEGFP-
SmHMGB1-S172A/S174A or empty pEGFP plasmids, using
Lipofectamine
TM 2000 (Invitrogen). Cells were observed 24 h
after transfections and proceeded with the treatment of 100 nM
okadaic acid (OA) for 6 h to inhibit protein phosphatases and thus,
enhance phosphorylation. Another batch of cells was pre-treated
with 75 mM 4,5,6,7- tetrabromobenzotriazole (TBBt, a specific
CK2 inhibitor) [31] for 1 h and then treated with OA (as above).
Controls included cells expressing EGFP-SmHMGB1, EGFP-
SmHMGB1-S172A/S174A or empty EGFP, without any treat-
Phosphorylation Mediates Schistosome HMGB1 Release
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(CytoTox 96, Promega) and by Trypan Blue staining.
EGFP imaging
Cells expressing EGFP-SmHMGB1, EGFP-SmHMGB1-
S172A/S174A or EGFP alone, treated with TBBt and/or OA,
and non-treated controls were fixed in 4% Paraformaldehyde for
1 h at room temperature. After fixation, cells were washed with
PBS 16. Nuclei were stained with DAPI for 5 min at room
temperature. Images were taken on a Zeiss Axio Observer.Z1
invert microscope equipped with 1006 objective lens and an
AxioCam MRm camera, in the ApoTome mode.
Transmission Electron Microscopy and Immunolabeling
S. mansoni male-adult worms were obtained from saline hepatic
perfusion, fixed in 0.7% glutaraldehyde (v/v), 0.1% picric acid,
1% sucrose, 2% paraformaldehyde, and and 5 mM CaCl2 in
0.1 M cacodylate buffer (pH 7.2), dehydrated in ethanol and
embedded in Unicryl (Ted Pella, Redding, CA). Ultrathin sections
were quenched in 50 mM NH4Cl for 30 min and incubated in the
presence of polyclonal anti-SmHMGB1 antibodies. After several
washes in PBS 16 and 1% BSA, sections were incubated in the
presence of 10 nm of gold-labeled goat anti-rabbit IgG (BB
International, UK), washed, and observed in a Zeiss 900 electron
microscope. Negative control sections were performed using pre-
immune serum (Figure S2).
Western blotting
Total extract of adult paired-worms was generated by tissue
homogenization with PBS 16i nt h ep r e s e n c eo fap r o t e a s ei n h i b i t o r
cocktail (SIGMA) followed by 14.0006g centrifugation. Supernatant
was collected and contained total soluble proteins. The cytoplasmic
and nuclear fractions from 100 couples of adult worms were
separated using Cell Lytic
TM Nuclear
TM Extraction Kit (SIGMA).
Briefly, the worms were washed in cold PBS 16, incubated in a
h y p o t o n i cl y s i sb u f f e r( 1 0 0m MH E P E S ,p H7 . 9 ,1 5m MM g C l 2,
100 mM KCl) and centrifuged at 1.0006 g. The supernatant
(cytoplasmicfraction)waskeptincoldandthepellet(nuclearfraction)
was resuspended in extraction buffer (20 mM HEPES pH 7.9,
1.5 mM MgCl2, 0.42 M NaCl, 0.2 mM EDTA and 25% (v/v)
glycerol). The nuclear fraction was obtained by 20.0006 g
centrifugation. Protein concentration was determined by the Bio-
Rad Protein Assay (Bio-Rad). Western blot analysis was carried out
using polyclonal anti-SmHMGB1 or anti-acetylated histones (a kind
g i f to fD r .C r i s t i n aM o t t a ,I n s t i t u t od eB i o f ı ´sica, UFRJ), and a HRP-
labeled anti-rabbit as the secondary antibody. Blots were developed
with ECL enhanced chemiluminescent reagents (Pierce).
Immunoprecipitation
Total extract of adult worms was generated as described above.
Nuclear and cytoplasmic fractions were pre-cleared by incubation
with protein A/G-Sepharose (Santa Cruz) at 4uC for 30 min. The
pre-cleared extracts (500 mg) were incubated with rabbit poly-
clonal anti-SmHMGB1 for 15 h at 4uC and then protein A/G-
Sepharose was added and incubated for 3 h at 4uC. Immunepre-
cipitated complexes were collected by centrifugation and extensive
washed with PBS 16. Collected complexes were fractionated by
12% SDS-PAGE, blotted to membranes, and detected by rabbit
polyclonal anti-phosphoserine antibodies (Chemicon).
Immunohistochemistry
Livers from 60 day-S.mansoni infected Swiss mice were
immediately embedded in OCT medium in a pre-cooled breaker
of isopentene and frozen in liquid N2. Seven micrometer cryostat
sections were adhered to glass slides and fixed in cold acetone for
30 minutes at 220uC. The sections were washed three times with
PBS 16, 0.03% Triton X-100 and blocked with PBS 16and 5%
BSA for 30 minutes. The sections were incubated with polyclonal
anti-SmHMGB1 and/or monoclonal anti-phosphoserine (SIG-
MA) in PBS 16 for 15 h at 4uC. After washing, an Alexa Fluor
488 conjugated anti-rabbit (Invitrogen) and/or an Alexa Fluor 555
conjugated anti-mouse (Invitrogen) were added for 1 h at room
temperature. Negative controls were obtained using only second-
ary antibodies. The sections were mounted in prolongH Gold
antifade reagent with DAPI (Invitrogen). All experiments were
repeated three times, and representative images were taken by a
Leica TCS SP5 AOBS confocal microscope.
Results
In vitro analysis of SmHMGB1 phosphorylation
HMGB1 from different organisms (mammalian, insects and
plants) have been shown to be substrates for different kinases
(CaMK, PKC, cdc2, CK2) [16–19]. Since these phosphorylations
proved to be important for the biological functions of these
different HMGB1 proteins, we asked the question whether
SmHMGB1 could also be phosphorylated. First, we subjected
the full amino acid sequence of SmHMGB1 to an in silico analysis
using the software NetPhosK 1.0 server (http://www.cbs.dtu.dk/
services/NetPhosK). The program revealed putative phosphory-
lation sites for CK2, PKC and PKA. The CK2 putative sites were
identified at positions S167, T169, S172 and S174 and we used an
in vitro biochemical approach to identify the actual CK2
phosphorylation site(s) of SmHMGB1. We performed phosphor-
ylation reactions with recombinant full length SmHMGB1 (FL),
but also assayed other SmHMGB1 gene constructions (Figure 1),
individually (see below). We showed that SmHMGB1-FL was a
specific substrate for commercial CK2 (Figure 2A). Specificity was
demonstrated by addition of heparin, a well-known inhibitor of
CK2, which completely abolished SmHMGB1 phosphorylation
(Figure 2A, lane 6). Moreover, the use of a synthetic specific
inhibitor of CK2, tetrabromobenzotriazole, TBBt, completely
abolished phosphorylation of SmHMGB1 (not shown). Since
CK2, PKA and PKC of S. mansoni were identified in the genome
and transcriptome database of the parasite, we assumed that the
parasite total protein extract could be a good source of
endogenous kinases. We then tested the capacity of this extract
to phosphorylate SmHMGB1. In fact, we were able to show that
endogenous kinases present in the extract of adult worms were
able to phosphorylate the recombinant SmHMGB1-FL
(Figure 2B). To evaluate the participation of the endogenous
schistosome CK2 in this process, we made use of the CK2 specific
inhibitor, TBBt (we avoided using heparin because being a
polyanion it could be sequestered by positive molecules present in
the extract). TBBt was able to consistently inhibit to 43%
(quantified by ImageJ-NIH Software) the phosphorylation of
SmHMGB1 (Figure 2B, lanes 2 and 3). Knowing that TBBt
inhibited phopshorylation by CK2 only, we assumed that other
kinases could be active in the extract of S. mansoni. Considering the
results from the NetPhosK program, that also identified putative
sites for PKC and PKA, we tested the ability of these two enzymes
to phosphorylate recombinant SmHMGB1-FL. The results
showed that commercial PKC and PKA were able to phosphor-
ylate SmHMGB1-FL (Figure 2C, lanes 1 and 3). When we tested
several concentrations of PKC (Bisindolylmaleimide II, Calbio-
chem) or PKA (H89, LC Laboratories) inhibitors in reactions
containing commercial PKC, PKA or the total protein extract (as
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phosphorylation of recombinant SmHMGB1 were discrete (data
not shown). Although it is not clear to us why these inhibitions
were weak, it is relevant to point out that commercially available
inhibitors of PKA or PKC have been previously described to be
somewhat inefficient and/or non-specific in some biological
systems [18,32]. We next wanted to determine what regions or
domains of SmHMGB1 were being targeted by CK2. For these
phosphorylation experiments, we expressed the first four gene
constructs depicted in Figure 1 (recombinant His6-tagged
SmHMGB1 proteins: full length [FL], the protein lacking its
acidic C-terminal tail [DC], the HMG box domain A [domain A]
and the HMG box domain B [domain B]). We showed that only
the full length protein was phosphorylated by CK2 (Figure 3A,
lane 1). Importantly, the protein construct lacking its acidic C-
terminal tail (see Figure 1, DC and Figure 3B, DC) failed to be
phosphorylated (lane 2). This result indicated to us that the
phosphorylation site (s) of CK2 was (were) localized within the
seven acidic residues contained in the acidic tail of SmHMGB1 (aa
170–176, see Figure 1, FL).
Protein kinase CK2 phosphorylates serine and/or threonine
residues that are embedded around negatively charged amino
acids. The acidic tail of SmHMGB1 contains two serine residues
surrounded by three aspartic acid and two glutamic acid residues
(see Figure 3B, FL). This observation prompted us to introduce
point mutations at these two serine residues (see Figure 3B, S172A,
S174A and S172A/S174A) and perform phosphorylation reac-
tions using these mutants as substrates for CK2. The results
obtained with the double mutant (S172A/S174A) showed that the
two serine residues present in the acidic C-terminal tail of
SmHMGB1 were indeed the phosphorylation sites for CK2
(Figure 3C, lane 5). Phosphorylation reactions using the mutant
S172A consistently revealed a slight decrease in phosphorylation
signal when compared with the FL phosphorylation (Figure 3C;
compare lane 1 with lane 4). The weaker CK2-phosphorylation of
S172A could be due to partial conformational constraint of this
specific mutant.
Figure 1. Schematic diagram of the Schistosoma mansoni HMGB1 gene structure and constructed mutants. SmHMGB1 full length (FL)
consists of two DNA-binding domains, the HMG box A (aa 1–83), HMG box B (aa 84–169) and a short acidic C-terminal domain (170–176). DC (aa 1–
169) refers to SmHMGB1 lacking only its acidic C-terminal domain; domain A (aa 1–83) refers to SmHMGB1 lacking its HMG box B domain; domain B
(aa 84–169) refers to SmHMGB1 lacking its HMG box A domain; S172A refers to SmHMGB1 with a point mutation at serine 172, substituted by alanine;
S174A refers to SmHMGB1 with a point mutation at serine 174, substituted by alanine; S172A/S174A refers to SmHMGB1 with two point mutations at
serines 172 and 174, both substituted by alanine.
doi:10.1371/journal.pone.0023572.g001
Figure 2. In vitro kinase assay of SmHMGB1 phosphorylation.
(A) One mg of the recombinant SmHMGB1 full length protein (FL) was
used as a substrate for commercial CK2, at various incubation times, in
the presence of [c
32P]ATP. Heparin was included to show specific
inhibition of CK2. Phosphorylations were analyzed by 15% SDS-PAGE
and autoradiography (top panel). Bottom panel is the Coomassie blue
stained gel of the SmHMGB1-FL used in the reactions; (B) S. mansoni
adult worm total protein extract (4 mg) was used, as a source of kinases,
in in vitro phosphorylation reactions. One mg of recombinant
SmHMGB1-FL was incubated with the extract for 1 h in the presence
of [c
32P]ATP, and with (1.8 and 3.6 mM) or without TBBt, a specific CK2
inhibitor. TBBt was dissolved in DMSO and we used it as control. Top
panel: phosphorylation; bottom panel: Coomassie blue staining; (C) One
mg of recombinant SmHMGB1 full length protein (FL) was used as a
substrate for commercial PKA and PKC in phosphorylation reactions for
1 h in the presence of c[
32P]ATP. These experiments were repeated
three times.
doi:10.1371/journal.pone.0023572.g002
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Differently from canonical transcription factors, HMGB1
proteins do not exhibit DNA-sequence specificity. Alternatively,
HMGB1 exhibits a remarkably high affinity for distorted DNA
conformations such as supercoiled DNA, four-way junction DNA
and DNA bulges, but it can also actively distort DNA by bending
or supercoiling and changing of DNA topology [5]. In this work,
we used two well-established DNA assays for HMGB1 proteins
(supercoiling assay and T4 DNA ligase-mediated circularization
assay; see legend for details of the technique), to determine
whether phosphorylation influences SmHMGB1 DNA transac-
tions. Our data consistently showed that the supercoiling activities
of SmHMGB1 that was not phosphorylated (FL) or SmHMGB1
that was phosphorylated (pFL) by CK2 were basically the same
(Figure 4A; compare lanes 3–5 with 6–8). When we used the
double mutant in the supercoiling experiment (they were also
submitted to phosphorylation), no difference was observed
(compare lanes 3–5 with 9–11). The inclusion of the mutants in
this experiment aimed at certifying that, even though they would
not be phosphorylated, the amino acid substitutions themselves
would not alter the functionality of the protein. Similarly with the
supercoiling assay, when we performed DNA bending assays using
either a 123 bp-DNA fragment (Figure 4C) or a 66 bp-DNA
fragment (data not shown), the formation of minicircles were not
affected by phosphorylated SmHMGB1 (Figure 4C, compare
lanes 7–9 with lanes 10–18, which are controls lacking
components of the phosphorylation reaction). Recombinant
SmHMGB1 proteins were tested for their integrity and activity
before being submitted to phopshorylation reactions (lanes 4–6),
see figure legend for details (panels B and D are controls showing
that the SmHMGB1 proteins that were used in the reactions were
phosphorylated [pFL] or not [FL]). A pixel quantification of the
bands were performed and confirmed that no significant
differences were observed between phosphorylated (lanes 7–9)
and non-phosphorylated (lanes 10–18) SmHMGB1 (data not
shown).
Effect of phosphorylation in the nucleocytoplasmic
shuttling of SmHMGB1
To investigate whether phosphorylation of SmHMGB1 influ-
ences its nuclear transport in vivo, we made use of a mammalian
heterologous system (remember that heterologous cells had to be
used since a schistosome cell line is not yet available [30]. In
Figure 5, HeLa cells were transiently transfected with either EGFP
plasmid alone, EGFP-SmHMGB1 or EGFP-SmHMGB1-S172/
174A, and received treatments of okadaic acid (OA, a protein
phosphatase inhibitor that enhances phosphorylation) or TBBt (a
specific inhibitor of CK2).
Control cells that were transfected with EGFP plasmid alone,
not treated or treated with OA or/and TBBt revealed the presence
of EGFP either in the nucleus or in the cytoplasm (Figure 5, panels
A, B and C). Transfected cells that were not treated with OA
revealed the presence of EGFP-SmHMGB1 exclusively in the
nucleus (Figure 5, panel A). Treatment of transfected cells with
OA resulted in a significant translocation of nuclear EGFP-
SmHMGB1 to the cytoplasm (Figure 5, panel B). When
transfected cells were treated with TBBt prior to addition of
OA, no EGFP-SmHMGB1 was observed in the cytoplasm
(Figure 5, panel C), indicating that CK2 phosphorylation played
an important role in the traffic of SmHMGB1 from the nucleus to
the cytoplasm. Cells that were transfected with EGFP-
SmHMGB1-S172A/S174A (the construct that contains the
mutations at the two serine residues) but that received no
treatment, showed localization of the protein exclusively in the
nuclei (Figure 5, panel A). When these transfected cells were
treated with OA (panel B) or OA plus TBBt (panel C), no
cytoplasmic translocation was observed whatsoever, showing that
the CK2-phosphorylation sites of SmHMGB1 are important
mediators for the protein translocation.
Presence of native SmHMGB1 in the nucleus and
cytoplasm of adult S. mansoni cells
We have shown (figure 5) that SmHMGB1 can traffic between
the nucleus and cytoplasm of mammalian cells. In order to
determine whether SmHMGB1 can be found in these two cellular
compartments of S. mansoni cells, we used transmission electron
microscopy and immunolabeling of ultra-thin sections of male
adult worms (Figure 6). The electron microscopy of a male worm
cell depicts clearly the nucleus (N), nucleolus (Nc), and cytoplasm
(C). The nuclear membrane (arrowheads) is also registered
(Figure 6, panels a and b). Boxes a1, a2, b1 and b2 show at a
higher magnification the intense immunogold labeling of
SmHMGB1. The arrows indicate the presence of endogenous
SmHMGB1 in the nucleus, on the nuclear membrane and in the
cytoplasm of a schistosome cell. No labeling was observed (control)
when sections were performed with pre-immune serum (Figure
S2).
Active and phosphorylated SmHMGB1 in the cytosolic
fraction of S. mansoni cells
Besides electron microscopy, we used biochemical approaches
with protein extracts from adult worms to determine if
SmHMGB1 is endogenously phosphorylated. When we reacted
the total extract of S. mansoni against SmHMGB1 antibody, two
bands with slightly differences in size were consistently detected
(Figure 7A, top panel, lane 1). When the nuclear extract was
reacted against SmHMGB1 antibody, only the lower molecular
Figure 3. Mapping of CK2 phosphorylation sites in SmHMGB1.
(A) One mg of the recombinant SmHMGB1-FL, SmHMGB1-DC,
SmHMGB1-domain A and SmHMGB1-domain B were assayed for CK2
phosphorylation, as described in Figure 2. Top panel shows phosphor-
ylation of SmHMGB1-FL (lane 1); no phosphoprylation was observed
with the deleted constructions (lanes 2–4). Bottom panel shows the
Coomassie blue staining of the purified recombinant proteins used in
the phosphorylation assay. (B) Only part of the protein is represented
(from aa 162 to the end of the protein) to show where the point
mutations took place. The two serine residues located at the acidic C-
terminal tail of SmHMGB1-FL were substituted to alanines (in red),
accordingly. (C) One mg of the recombinant SmHMGB1-FL, SmHMGB1-
DC or mutated constructs were assayed for CK2 phosphorylation. These
experiments were repeated three times.
doi:10.1371/journal.pone.0023572.g003
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when the cytosolic extract was reacted against the same antibody,
only the higher molecular band was detected (Figure 7A, top
panel, lane 3). These results prompted us to test whether this slight
difference in protein size found only in the cytosolic fraction could
be due to phosphorylation. When we immunoprecipitated
SmHMGB1 proteins from the nuclear or cytosolic extracts and
then reacted them against an anti-phosphoserine antibody, we
observed that the cytosolic SmHMGB1 was highly phosphorylated
(Figure 7A, bottom panel, lane 3). Alternatively, SmHMGB1 that
was present in the nucleus showed only residual phosphorylation
(Figure 7A, bottom panel, lane 2).
Since we showed that phosphorylation of recombinant
SmHMGB1 did not interfere with its DNA binding activity
(Figure 4), we then wanted to test if phosphorylation of
endogenous SmHMGB1 would behave similarly. For this, we
performed the T4 DNA ligase-mediated circularization assay (or
DNA bending assay) using S. mansoni total, nuclear or cytosolic
extracts as source of phosphorylated or non-phosphorylated
SmHMGB1 (Figure 7B). When we used the total extract, a
significant formation of circles (DNA bending) was observed
(Figure 7B, lane 4). When the nuclear or cytosolic extracts were
used, the formation of circles was also observed (Figure 7B, lanes 5
and 6). It is important to point out that the activity of the nuclear
Figure 4. DNA supercoiling and bending assays by phosphorylated SmHMGB1. (A) Circular relaxed plasmid pTZ19R DNA was incubated in
the presence of topoisomerase I with 1 mg of recombinant SmHMGB1-FL or SmHMGB1-S172A/S174A that were phosphorylated (lanes 3–5) or not
(lanes 6–8 and 9–11), by CK2. Deproteinized DNA topoisomers were resolved on 1% agarose gels, followed by staining of the gels with ethidium
bromide. Form I, supercoiled DNA; form II, relaxed circular DNA. (B) Top panel: autoradiography; bottom panel: Coomassie staining. (C) A
32P-labeled
123-bp DNA fragment (,1 nM) was pre-incubated with 50 ng of recombinant proteins, that were phosphorylated (lanes 7–9) or not (lanes 4–6, 10–
12, 13–15 and 16–18), followed by ligation with T4 DNA ligase. Exonuclease III was used to verify the identity of DNA circles. The deproteinized DNA
ligation products were subjected to electrophoresis on 6% non-denaturing polyacrylamide gels and visualized by autoradiography. Controls are as
follows: FL(c1): SmHMGB1-FL without CK2; FL(c2): SmHMGB1-FL without phosphate; FL(c3): SmHMGB1-FL without CK2 buffer. Linear: linear DNA; Lm:
linear multimers. (D) Top panel: autoradiography; bottom panel: Coomassie staining. These experiments were repeated four times.
doi:10.1371/journal.pone.0023572.g004
Figure 5. Phosphorylation of SmHMGB1 mediates its cellular traffic in HeLa cells. HeLa cells were transfected with empty control plasmid
pEGFP, pEGFP-SmHMGB1-FL or pEGFP-SmHMGB1-S172A/S174A plasmids and untreated (panels A) or treated with 100 nM okadaic acid (OA) for 6 h
(panels B) or with OA+75 mM TBBt (panels C). SmHMGB1-EGFP fusion proteins were detected by fluorescence microscopy. Nuclei were stained with
DAPI. Cell viability was assessed by Trypan blue and LDH activity (data not shown). Scale bar 3 mm. This result is a representative of four independent
experiments.
doi:10.1371/journal.pone.0023572.g005
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SmHMGB1 (presumably phosphorylated) were comparable. We
were able to prove that the formation of the circles was a result of
the activity of the nuclear or cytosolic SmHMGB1 by the addition
of an anti-SmHMGB1 antibody prior to the bending reaction,
where no circles were formed (Figure 7B, lanes 7 and 8). To
further confirm that SmHMGB1 antibody was not unspecifically
targeting the ligase reaction, we carried out an additional DNA
bending reactions containing SmHMGB1 specific antibody,
heparin (which can sequester HMGB1) or the pre-immune serum
(Figure S1, see legend for details).
The formation of circles was determined by the treatment of
Exonuclease III (Exo III), an enzyme that degrades only linear
DNA, but not circular DNA. Linear multimers (Lm) were also
observed (HMGB1 proteins are known to enhance the formation
of linear multimers by the T4 DNA ligase) [33].
To certify that the cytosolic extract was not contaminated with
nuclear proteins, we performed a Western blot (Figure 7C) with S.
mansoni nuclear or cytosolic extracts and reacted them against anti-
acetylated histone antibodies. Figure 7C shows that histones were
only detected in the nuclear extract.
Phosphorylated SmHMGB1 is amply distributed in
schistosomotic granuloma
Considering the role of phosphorylation in the extracellular
release of mammalian HMGB1 as well as the pro-inflammatory
activity of the protein in modulating the pathogenesis of several
inflammatory diseases, we next evaluated the phosphorylation
status of SmHMGB1 proteins that were secreted and lodged in
the schistosomotic liver granuloma. By immunofluorescence
assays using an anti- SmHMGB1 antibody, we were able to
demonstrate the presence of a significant amount of SmHMGB1
in the eggshell and a considerable amount of egg-released
SmHMGB1 throughout the granulomatous liver tissue (Figure 8,
panel 2). We next used anti-phosphoserine antibodies and
showed that a number of proteins present in the host
granulomatous liver were phosphorylated (Figure 8, panel 3).
Co-localization analysis confirmed that a large amount of egg-
secreted SmHMGB1 proteins were phosphorylated (Figure 8,
panel 4, merge of 2 and 3, orange arrows). Immunoreaction with
the secondary antibody only, revealed the previously described
auto-fluorescence of the eggshell [34] (Figure 8, panels 2, 3 and
4; Figure S3). Molecules that were red-labeled only (in panel 3,
and red arrows in panel 4), likely represent serine-phosphory-
lated proteins from the host and possible from the schistosome
eggs. However, a smaller proportion of the SmHMGB1 proteins
that were not modified by phosphorylation were identified in the
granulomatous liver tissue (green arrows in panel 4). It is possible
that this population of SmHMGB1 proteins (green fluorescence
only) could have reached the extracellular space through other
modifications, such as acetylation and/or methylation. Indeed,
acetylation of SmHMGB1 plays a role in its cellular exit [28]. In
addition, we have shown that SmHMGB1 is arginine-methylated
(unpublished results). Importantly, one cannot exclude the
possibility that extracellular SmHMGB1 molecules carry multi-
ple modifications. In fact, the interdependence of the post-
synthetic acetylation and phosphorylation of mHMGB1 has
been reported [35].
In order to evaluate the biochemical profile of extracellular
SmHMGB1 proteins located in the granuloma (Figure 8, panel 4),
we performed a Western blot analysis and confirmed that egg-
secreted SmHMGB1 proteins were modified by phosphorylation
(Figure 8B, top band).
Discussion
HMGB1 proteins have evolved and developed the ability to act
both as nuclear factors for the regulation of gene transcription and
to contribute to the induction of innate and adaptive immune
responses by activating membrane receptor-mediated signal
transduction pathways. The combination of transcriptional and
extracellular capabilities provides them with the dual capacity of
promoting gene expression and mobilizing host defense.
Treatment with inhibitors (anti-HMGB1 antibodies and
pharmacological agents) of the mammalian HMGB1 pro-inflam-
matory activity is beneficial and reduces inflammation in a dozen
of preclinical animal studies [9–10,36–38]. Therefore, substantial
work has been conducted to elucidate the mechanisms by which
HMGB1 is released. Current data support an active process
initiated by HMGB1-histone disengagement, HMGB1 hyperace-
tylation, and shuttling of the protein from the nucleus to cytoplasm
[6]. Phosphorylation of HMGB1 has also been demonstrated to be
essential for this translocation event [16–18].
In the present work we aimed to determine the role of
phosphorylation of SmHMGB1 in its nucleocytoplasmic shuttling
and to correlate its extracellular location to its ability to trigger
inflammation.
Despite the overall homology between SmHMGB1 and
mHMGB1, their phosphorylation statuses are somewhat distinct.
Mammalian HMGB1 has been shown to be phosphorylated by
CaMK [17] and PKC [18] and at serine residues located at the
two putative NLS, one localized in the HMG box A and the other
localized between the HMG box B and the acidic tail [6].
Recently, it has been assumed that serine phosphorylation of
mHMGB1 NLS may reduce its DNA-binding and cooperates to
Figure 6. In situ localization of native SmHMGB1 protein in the
nucleus and cytoplasm of S. mansoni cells. (a and b) Transmission
electron microscopy (TEM) of cells from S. mansoni male adult worms
showing the nucleus (N), nucleolus (Nc), cytoplasm (C) and the nuclear
membrane (arrowheads). Insets a1, a2, b1 and b2 depict a closer
visualization of the interface between the nucleus and the cytoplasm.
The immunogold staining shows the labeling of SmHMGB1 in both
cellular compartments (arrows indicate representative SmHMGB1
labeling). Bars: a and b=100 nm; a1 and a2=50 nm. This image is a
representative of several cells observed under TEM.
doi:10.1371/journal.pone.0023572.g006
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been performed by these authors to prove this assumption.
In the case of SmHMGB1, phosphorylation was achieved by
PKC, PKA and CK2 (figure 2). CK2 phosphorylation (but not
PKC or PKA) was mapped at serines 172 and 174, both located
within the short C-terminal acidic tail of the protein (Figure 3).
SmHMGB1 contains one putative nuclear localization signal
(NLS), at positions (residues) 87 to 90, localized in the linker
between the HMG box A and B, and a putative nuclear
exportation signal (NES), at positions 101 to 110, localized in
the HMG box B domain [26]. By performing DNA-binding assays
amply used to test HMGB1 activities, we clearly showed that
phosphorylation of either recombinant or native SmHMGB1, did
not enhance or reduce their DNA-binding activities (Figure 4 and
7).
Mammalian HMGB1 is a very mobile nuclear protein and the
association of mHMGB1 with chromatin is transient [39]. The
nucleosome would be visited by mHMGB1 every 2 seconds and
the protein would stay there for a small fraction of a second [40].
Thus, mHMGB1 is continuously and rapidly exchanged between
cytoplasm and chromosomes. Here, with the results of Figure 6,
we showed that under a physiological condition, SmHMGB1
protein was localized in the nucleus, in the nuclear membrane and
in the cytoplasm of an adult worm cell, supporting the notion that
SmHMGB1 traffics between these two compartments. Additional
data from this work suggested that phosphorylation of SmHMGB1
was involved in the shuttle of the protein from the nucleus to the
cytoplasm (Figure 5), with its subsequent release to the
extracellular space (Figures 8). It is worth to point out that in
the case of SmHMGB1, secretion seemed to be dependent of
phosphorylation by CK2.
For mHMGB1, it has been shown that the protein was
imported to the nucleus by KAP-a1 as a nuclear cargo carrier
protein after translation and eventually accumulated in the nucleus
[16]. However, a significant fraction of HMGB1 cannot re-enter
the nucleus if it has been exported from the nucleus due to
phosphorylation [16]. Moreover, inhibition of the exportin protein
Crm1 showed a marker reduction of cytoplasmic phosphorylated
HMGB1 [19]. Thus, in addition to acetylation, the subcellular
localization of mHMGB1 is finely tuned by phosphorylation,
although it is still unknown which modification is dominant under
physiological conditions.
In the case of SmHMGB1 phosphorylation, while at this
moment we can not anticipate which signaling pathway is
activated by this modification, with the data presented here we
can envision a remarkable role of SmHMGB1 phosphorylation in
the modulation of the pathophysiology of schistosomiasis.
In infection with S. mansoni, chronic disease is the result of the
ongoing host response to accumulating tissue-trapped eggs, with
the liver being the principal site affected. Hepatic granuloma are
pathogenic because they precipitate fibrosis, which obstructs blood
flow, increases portal blood pressure, and ultimately, promotes
development of portal-systemic venous shunts [41]. In this work,
based on the data that phosphorylated SmHMGB1 is extracellu-
larly released by tissue-trapped eggs, we would like to propose a
model where SmHMGB1 can act as a novel egg antigen,
promoting inflammation and contributing to granuloma forma-
tion.
Figure 7. Endogenous phosphorylation of SmHMGB1 did not alter its DNA bending activity. (A) Western blot analysis was carried out
with S. mansoni protein extracts and an anti-SmHMGB1 polyclonal antibody. SmHMGB1 antibodies detected two proteins in the total extract (top
panel, lane 1). The lower molecular weight protein was detected in the nuclear extract only (top panel, lane 2); the higher molecular weight protein
was detected in the cytosolic extract only (top panel, lane 3). SmHMGB1 that was immunopreciptated from the nuclear or cytosolic extracts using
SmHMGB1 antibodies were reacted against anti-phosphoserine antibodies in a Western blot (bottom panel, lane 2 (nuclear extract) and 3 (cytosolic
extract); phosphorylation of SmHMGB1 at serines is indicated by pSmHMGB1). (B) Bending assay: a
32P-labeled 123-bp DNA fragment (1 nM) was pre-
incubated with 10 mg of total (lane 4), 4 mg of nuclear (lane 5) or 4 mg of cytosolic (lane 6) protein extracts from S. mansoni adult worms, and the
assay performed as described in Figure 4C. To make sure that the circles were formed by the activity of SmHMGB1, nuclear or cytosolic (lanes 7 and 8,
respectively) extracts were incubated with anti-SmHMGB1 antibodies prior bending reactions. Extracts that were incubated with SmHMGB1 antibody
did not show any circularization (or bending) activity (lanes 7 and 8). The Exo III control proved the identity of the circles. (C) Top panel: SDS-PAGE of
S. mansoni adult worm nuclear (N) or cytosolic (C) extracts. Bottom panel: Western blot with anti-acetylated histones, showing no cross-
contamination between the two extracts. These experiments were repeated three times.
doi:10.1371/journal.pone.0023572.g007
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secreted by larvae schistosomula and eggs [27]. In vitro,
recombinant SmHMGB1 was shown to be a potent inducer of
pro-inflammatory cytokines including TNF-a, IL-13, IL-13Ra1,
MIP-1a and others [27]. Interestingly, migration of mHMGB1 to
organs or tissue sites induced similar pro-inflammatory cytokines,
such as TNF-a, IL-1a, IL-1b, IL-1RA, IL-6, IL-8, MIP-1a and
MIP-1 b [42].
Tumor necrosis factor-a and IL-13 are believed to provide
necessary immune priming for the formation of schistosomotic
granuloma [43–46]. Although the actual role of TNF-a in
schistosomiasis is still debated [47–49], several lines of research
have implicated this molecule in the chronic form of the disease
[50–52]. In this regard, TNF-a and HMGB1 have been intimately
linked to the pathology of several inflammatory diseases, such as
sepsis, rheumatoid arthritis and Crohn’s disease [53].
The inflammatory activity of mHMGB1 is dependent upon
the oxidation status of the cysteine 106 residue within the HMG
box B of the mammalian protein, a region that is critical for
stimulating cytokine release and inflammation [10,54–55].
Importantly, the pro-inflammatory activity of SmHMGB1 also
appears to be the function of its HMG box B domain [27]. In
addition, the cysteine residue 106 is conserved in the
SmHMGB1 molecule [26]. A recent study has revealed that
cysteine 106 is critically important for mHMGB1 binding to
TLR4 [56]. Together, these results indicate that cysteine 106 is
required for mHMGB1 (and we believe for SmHMGB1, as well)
signaling through TLR4 to stimulate cytokine release and
inflammation.
It has been recently demonstrated that the larvae schistosomula
tegument activated dendritic cells (DC) to produce IL-12p40,
TNF-a and also co-stimulatory molecules CD40 and CD86
through a TLR4-dependent pathway [57]. This finding is
especially important because it has been shown that mHMGB1
acts as adjuvant via DC activation, maturation and mobilization
[42].
In conclusion, in addition to previously described acetylation,
we showed in this study that the subcellular localization and
secretion of SmHMGB1 was regulated by phosphorylation.
Importantly, we showed that phosphorylated SmHMGB1 was
secreted by the eggs that were lodged in the liver of infected mice.
We believe that this study will open up a new area of investigation
for those interested in understating the pathogenesis of schistoso-
miais.
Figure 8. Localization of phosphorylated SmHMGB1 in the granulomatous liver. (A) Immunostaining of hepatic granuloma with a S.
mansoni egg in the center. Nuclei were stained with DAPI (1); Detection of SmHMGB1 using an anti-SmHMGB1 polyclonal antibody (2). Detection of
phosphorylated SmHMGB1 using an anti-phosphoserine monoclonal antibody (3). A significant amount of secreted SmHMGB1 detected in the
granulomatous liver is phosphorylated (merged images of panels 2 and 3). In panel 4, green arrows point to secreted but non-phosphorylated
SmHMGB1; red arrows point to phosphorylated proteins from the host; orange arrows point to secreted phosphorylated SmHMGB1. Controls with
the pre-immune sera (not shown) or with the secondary antibody only (Figure S3), exhibited a residual auto-fluorescence from the eggshell. Scale bar:
20 mm. This figure is a representative of the several egg-induced granuloma analyzed from three independent mice livers. (B) Eggs (,10
6 eggs) from
these livers were processed and egg secretions (ES) were assayed by Western blot using anti-SmHMGB1 antibody. The two isoforms (phosphorylated
and unphosphorylated) of SmHMGB1 were detected in egg secretions. However, the high molecular weight (phosphorylated) isoform is significantly
more abundant in egg secretions (top band).
doi:10.1371/journal.pone.0023572.g008
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Figure S1 DNA bending assay. A
32P-labeled 123 bp-DNA
fragment (1 nM) was pre-incubated with 10 mg of total extract
from S. mansoni adult worms (lanes 3–7), 250 ng of recombinant
SmHMGB1 (lanes 8–12). Samples in lanes 5 and 9 were pre-
incubated with anti-SmHMGB1 antibody; samples in lanes 6 and
10 were pre-incubated with heparin; samples in lanes 7 and 11
were pre-incubated with the pre-immune serum. The ExoIII
control proved the identity of circles (lanes 3 and 12). Two
independent experiments showed the same results.
(TIF)
Figure S2 Negative control of the transmission electron
microscopy (TEM) of cells from S. mansoni male adult
worms. No immunogold staining was observed when the pre-
immune serum was used. Nucleus (N), nucleolus (Nc) and
endoplasmic reticulum (ER). Scale bar 150 nm.
(TIF)
Figure S3 Auto-fluorescence of S. mansoni eggshell.
Hepatic granuloma with a S. mansoni egg in the center was reacted
using an Alexa 555 anti-mouse secondary antibody. The auto-
fluorescence of S. mansoni eggshell is observed. Scale bar: 20 mm.
(TIF)
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